Prab at 17:02, 22 March 2025

2025-03-22T17:02:15Z

← Older revision		Revision as of 17:02, 22 March 2025
Line 31:		Line 31:
	{{stub}}		{{stub}}
	{{No image}}		{{No image}}
	~~__NOINDEX__~~

Prab: CSV import

2025-03-17T11:03:02Z

CSV import

← Older revision		Revision as of 11:03, 17 March 2025
Line 31:		Line 31:
	{{stub}}		{{stub}}
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-10T16:45:32Z

CSV import

← Older revision		Revision as of 16:45, 10 February 2025
Line 30:		Line 30:

	{{stub}}		{{stub}}
			{{No image}}

Prab: CSV import

2024-02-22T20:59:11Z

CSV import

New page

'''Endpoint''' is a term used in [[clinical trials]] to refer to an event or outcome that can be measured objectively to determine whether the intervention being studied is beneficial. The endpoints of a clinical trial are usually included in the study objectives. Some examples of endpoints are survival, improvements in quality of life, relief of symptoms, and disappearance of the tumor.

==Types of Endpoints==
There are several types of endpoints that can be used in clinical trials, including:

* '''[[Primary Endpoint]]''': This is the main result that is measured at the end of a study to see if a given treatment worked.
* '''[[Secondary Endpoint]]''': These are the measures that are of secondary interest or that are not as important as the primary endpoint.
* '''[[Tertiary Endpoint]]''': These are the endpoints that are only looked at as exploratory information.

==Choosing the Right Endpoint==
The choice of endpoint is crucial in the design of a clinical trial. The endpoint should be relevant to the patient and the disease being studied. It should also be measurable and sensitive to changes in the patient's condition. The choice of endpoint can also affect the length and cost of the trial, as well as the strength of the evidence generated.

==Endpoints in Different Phases of Clinical Trials==
In different phases of clinical trials, different types of endpoints are used. For example, in [[Phase I trials]], the endpoint is usually safety, while in [[Phase II trials]], the endpoint is usually efficacy. In [[Phase III trials]], the endpoint is usually the comparison of the new treatment with the standard treatment.

==Challenges in Defining Endpoints==
There are several challenges in defining endpoints for clinical trials. One challenge is that the endpoint may not be directly observable, but must be inferred from other measurements. Another challenge is that the endpoint may not be a single event, but a composite of several events.

==See Also==
* [[Clinical trial]]
* [[Primary Endpoint]]
* [[Secondary Endpoint]]
* [[Tertiary Endpoint]]
* [[Phase I trials]]
* [[Phase II trials]]
* [[Phase III trials]]

[[Category:Medical Terms]]
[[Category:Clinical Trials]]

{{stub}}

Endpoint - Revision history

Prab at 17:02, 22 March 2025

Prab: CSV import

Prab: CSV import

Prab: CSV import